Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
79.80
Dollar change
+0.63
Percentage change
0.80
%
IndexRUT P/E- EPS (ttm)-5.20 Insider Own18.14% Shs Outstand47.35M Perf Week-1.31%
Market Cap3.78B Forward P/E105.46 EPS next Y0.76 Insider Trans-0.37% Shs Float38.78M Perf Month-3.80%
Income-239.24M PEG- EPS next Q-1.18 Inst Own80.88% Short Float18.82% Perf Quarter-4.56%
Sales270.60M P/S13.97 EPS this Y30.10% Inst Trans16.51% Short Ratio9.52 Perf Half Y10.42%
Book/sh4.03 P/B19.79 EPS next Y120.54% ROA-52.02% Short Interest7.30M Perf Year29.74%
Cash/sh8.15 P/C9.79 EPS next 5Y- ROE-159.21% 52W Range55.02 - 98.40 Perf YTD0.26%
Dividend Est.- P/FCF- EPS past 5Y-35.53% ROI-63.61% 52W High-18.90% Beta1.12
Dividend TTM- Quick Ratio3.52 Sales past 5Y88.16% Gross Margin87.43% 52W Low45.04% ATR (14)3.84
Dividend Ex-Date- Current Ratio3.63 EPS Y/Y TTM-13.57% Oper. Margin-67.59% RSI (14)52.09 Volatility5.55% 5.12%
Employees545 Debt/Eq0.98 Sales Y/Y TTM440.80% Profit Margin-88.41% Recom1.31 Target Price121.50
Option/ShortYes / Yes LT Debt/Eq0.97 EPS Q/Q-47.88% Payout- Rel Volume0.64 Prev Close79.17
Sales Surprise3.31% EPS Surprise-77.57% Sales Q/Q193.50% EarningsFeb 20 BMO Avg Volume766.75K Price79.80
SMA205.33% SMA50-4.95% SMA2005.67% Trades Volume487,583 Change0.80%
Date Action Analyst Rating Change Price Target Change
Mar-19-24Initiated Robert W. Baird Outperform $108
Feb-06-24Initiated UBS Buy $111
Jan-25-24Initiated RBC Capital Mkts Outperform $126
Dec-13-23Initiated Citigroup Buy $125
Aug-08-23Upgrade BofA Securities Underperform → Neutral $59 → $81
Jan-05-23Initiated Piper Sandler Neutral $75
Nov-01-22Initiated Loop Capital Buy $95
Sep-07-22Resumed Mizuho Buy $49 → $76
Aug-10-21Downgrade Morgan Stanley Overweight → Equal-Weight $105 → $34
Jun-10-21Initiated Berenberg Buy $112
Mar-26-24 11:24AM
06:24AM
04:56AM
Mar-25-24 07:00AM
06:30AM
06:45AM Loading…
Mar-23-24 06:45AM
Mar-22-24 10:00AM
Mar-21-24 11:30AM
Mar-20-24 12:12PM
Mar-19-24 07:00AM
Mar-13-24 03:32PM
Mar-05-24 07:00AM
Feb-27-24 07:00AM
Feb-26-24 03:04PM
08:50AM
10:39AM Loading…
Feb-21-24 10:39AM
09:23AM
Feb-20-24 10:39PM
08:15AM
07:31AM
07:00AM
Feb-13-24 10:00AM
Feb-08-24 07:45AM
Jan-23-24 11:01AM
07:00AM
Jan-05-24 10:21AM
Jan-04-24 07:00AM
Jan-03-24 05:20AM
Jan-02-24 08:45AM
Jan-01-24 06:50AM
07:00AM Loading…
Dec-11-23 07:00AM
Dec-10-23 06:56AM
Dec-07-23 07:00AM
Nov-28-23 06:51PM
Nov-27-23 09:50AM
Nov-22-23 07:00AM
05:30AM
Nov-21-23 07:00AM
Nov-11-23 06:50AM
Nov-09-23 10:23AM
Nov-07-23 11:02AM
08:33AM
02:23AM
Nov-06-23 08:09AM
07:00AM
Nov-02-23 07:00AM
Oct-31-23 07:00AM
Oct-27-23 05:00AM
Oct-25-23 08:45AM
Oct-24-23 07:00AM
Oct-23-23 05:30AM
Oct-11-23 07:00AM
Oct-10-23 07:00AM
Oct-03-23 05:30AM
Oct-02-23 07:00AM
Sep-21-23 07:00AM
Sep-15-23 10:23AM
Sep-12-23 06:00AM
Sep-07-23 07:03AM
Sep-05-23 07:00AM
Aug-30-23 08:00AM
Aug-24-23 10:07AM
Aug-19-23 05:52AM
Aug-10-23 05:50AM
Aug-09-23 08:37AM
Aug-08-23 12:21PM
10:02AM
09:11AM
03:42AM
Aug-07-23 07:00AM
Aug-05-23 06:55AM
Aug-03-23 09:45AM
Aug-02-23 10:23AM
Jul-20-23 08:08AM
Jul-13-23 05:50AM
Jul-12-23 07:00AM
Jul-11-23 10:00AM
Jul-07-23 07:00AM
Jul-01-23 05:45AM
Jun-30-23 04:02PM
Jun-28-23 03:59PM
09:28AM
09:25AM
07:45AM
05:30AM
Jun-27-23 08:24PM
Jun-25-23 06:07AM
Jun-22-23 06:40AM
Jun-20-23 08:23AM
Jun-17-23 05:17AM
Jun-16-23 02:00PM
Jun-15-23 02:00PM
Jun-14-23 04:01PM
Jun-10-23 06:14AM
Jun-09-23 02:00PM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-28-23 10:15AM
May-26-23 09:37AM
May-22-23 07:45AM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JEFFS ROGERDirectorMar 15 '24Option Exercise29.912,34770,199123,103Mar 15 08:05 PM
JEFFS ROGERDirectorMar 15 '24Sale71.612,347168,062120,756Mar 15 08:05 PM
JEFFS ROGERDirectorMar 14 '24Option Exercise24.0129,976719,787137,732Mar 15 08:05 PM
JEFFS ROGERDirectorMar 14 '24Sale69.7029,9762,089,387120,756Mar 15 08:05 PM
Coleman MarkDirectorSep 15 '23Option Exercise3.6711,01640,42936,113Sep 15 06:30 PM
Coleman MarkDirectorSep 15 '23Sale75.1818,5721,396,189403,856Sep 15 06:30 PM
Coleman MarkDirectorSep 15 '23Sale75.1911,016828,24125,097Sep 15 06:30 PM